beta

GALE

Galena Biopharma Inc.

Gale

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-09-2017 08-14-2017 after market close 05-10-2017
Actual EPS -0.15 -0.16 -0.09
Consensus EPS -0.15 -0.15 -0.22
Estimated EPS -0.15 -0.15 -0.22
Number of Estimates 1 1 1
EPS Surprise -$0.01 $0.13

Stats

Summary

Galena Biopharma Inc is a biopharmaceutical company. It is focused on developing and commercializing targeted oncology therapeutics that addresses unmet medical needs.

Market Cap: 12 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.galenabiopharma.com

Shares Outstanding: 45.7 Million

Float: 44.1 Million

Dividend: 0.0 (0.0%)

Beta: 1.972845

Sector: Healthcare

Industry: Biotechnology

Short Interest (Dec 15, 2017): 122 Thousand

Ethical Flags

Animal testing

Longest drawdown: 996 trading days

From: 2014-01-16 To: 2017-12-29

Lowest Point:

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 11:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 11:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 11:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 11:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 11:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 11:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 06:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 06:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 06:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

Galena stockholders OK merger with SELLAS Life Sciences

via: SeekingAlpha at 2017-12-29 06:07:50:000

Galena Biopharama ( GALE +8.6% ) is higher after shareholders approve the company's merger deal with SELLAS Life Sciences. More news on: Galena Biopharma, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more … read more...

2017 YTD worst losers - healthcare

via: SeekingAlpha at 2017-12-22 11:00:14:000

Reminding investors of tears shed and fortunes lost, here are the top losers in healthcare this year: More news on: CHF Solutions, Inc., Argos Therapeutics, Inc., Dextera Surgical Inc., Healthcare stocks news, Read more … read more...

Your Daily Pharma Scoop: Valeant Still Risky, Onconova Signs Agreement, Array Biopharma Announces Collaboration

via: SeekingAlpha at 2017-12-20 05:46:56:000

Content Analysis of coverage: VRX Stocks in the news: ONTX, RGNX, ARRY Analyst Ratings Insider Sales Insider Purchases Earnings Report Secondary Offerings Earnings Calendar Trade Idea for the Day (for TPT subscribers only) Subscriber Questions & Ans… read more...

Your Daily Pharma Scoop: Neurocrine Has Upside, Dynavax Gets FDA Nod, Sage Soars

via: SeekingAlpha at 2017-11-12 00:20:46:000

This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Neurocrine Biosciences Today we will d… read more...

Galena Biopharma EPS in-line

via: SeekingAlpha at 2017-11-09 17:21:40:000

Galena Biopharma (NASDAQ: GALE ): Q3 EPS of -$0.15 in-line. Cash and equivalents of $12.9M. Press Release More news on: Galena Biopharma, Inc., Earnings news and commentary, Healthcare stocks news, , read more...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Galena Biopharma, Inc. - GALE

via: PR Newswire at 2017-10-31 18:34:00:000

NEW YORK , Oct. 31, 2017 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York City , is investigating Galena Biopharma, Inc. ("Galena" or the "Company"… read more...

SELLAS Life Sciences to collaborate with Merck on clinical trial assessing combo treatment for range of cancers; merger partner Galena up 6%

via: SeekingAlpha at 2017-10-02 15:48:39:000

Privately held SELLAS Life Sciences Group inks a clinical trial collaboration agreement with Merck ( MRK +0.8% )evaluating the combination of galinpepimut-S and Keytruda (pembrolizumab) in a range of cancers, including both blood cancers and solid tumors in a Phase 1/2 study. Mor… read more...

SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

via: PR Newswire at 2017-10-02 07:35:00:000

Initiation of a Phase 1/2 Combination Clinical Trial with Galinpepimut-S and KEYTRUDA (pembrolizumab) Across Various Indications Expected in 1H, 2018 HAMILTON, Bermuda and NEW YORK , Oct. 2, 2017 /PRNewswire/ -- SELLAS Life Sciences Group , Ltd. (SELLAS), a developme… read more...

SELLAS Enters into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc., Kenilworth, N.J., USA

via: PR Newswire at 2017-10-02 07:35:00:000

HAMILTON, Bermuda and NEW YORK , Oct. 2, 2017 /PRNewswire/ -- SELLAS Life Sciences Group , Ltd. (SELLAS), a development-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer indications, today announced entry into a Clinical Trial Coll… read more...

Galena Biopharma completes enrollment in two NeuVax clinical trials in combination with trastuzumab; shares ahead 10% premarket

via: SeekingAlpha at 2017-09-28 08:43:26:000

Galena Biopharma (NASDAQ: GALE ) announces that two clinical trials evaluating NeuVax (nelipepimut-S) in combination with trastuzumab (Herceptin; Genentech/Roche) for the prevention of recurrence in breast cancer patients have completed patient enrollment. More news on: Galena Biopha… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-11-14 20.0 1.0 20.0
Data provided by IEX Cloud